DOMAIN THERAPEUTICS
Domain Therapeutics is a biopharmaceutical company located in Strasbourg, France, dedicated to the discovery and early development of small molecules targeting G-coupled Protein Receptors (GPCRs), one of the best classes of drug targets. Domain Therapeutics is using its innovative and proprietary technology platform DTect-Allâ„¢ to identify orthosteric and allosteric ligands of GPCRs, including the so called Silent Allosteric Modulators (SAMs) that represent a unique source of compounds that cannot be discovered by standard technologies. DTect-Allâ„¢ is able to address difficult GPCRs such as orphan and peptidic GPCRs.
DOMAIN THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2001-01-01
Address:
Illkirch, Alsace, France
Country:
France
Website Url:
http://www.domaintherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+33 3 90 40 61 50
Email Addresses:
[email protected]
Total Funding:
89.28 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Domain Not Resolving
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Omnes Capital
Omnes Capital investment in Series A - Domain Therapeutics
Seventure Partners
Seventure Partners investment in Series A - Domain Therapeutics
Theodorus III
Theodorus III investment in Series A - Domain Therapeutics
3B Future Health Fund
3B Future Health Fund investment in Series A - Domain Therapeutics
Viva BioInnovator
Viva BioInnovator investment in Series A - Domain Therapeutics
Turenne Capital
Turenne Capital investment in Series A - Domain Therapeutics
adMare Bio Innovations
adMare Bio Innovations investment in Series A - Domain Therapeutics
Panacea Venture
Panacea Venture investment in Series A - Domain Therapeutics
Schroders Capital
Schroders Capital investment in Series A - Domain Therapeutics
CTI Life Sciences Fund
CTI Life Sciences Fund investment in Series A - Domain Therapeutics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-09-12 | Ermium Therapeutics | Domain Therapeutics investment in Series A - Ermium Therapeutics | 6.3 M EUR |
| 2016-10-18 | Mavalon Therapeutics | Domain Therapeutics investment in Seed Round - Mavalon Therapeutics | 9 M EUR |
Official Site Inspections
http://www.domaintherapeutics.com Semrush global rank: 3.76 M Semrush visits lastest month: 3.58 K
- Host name: cluster002.hosting.cdn.ovh.net
- IP address: 46.105.204.2
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Domain Therapeutics"
Our Company - Domain Therapeutics Group
A unique GPCR company dedicated to immuno-oncology. Domain Therapeutics is a global clinical-stage biopharmaceutical company, pioneering the unique and visionary approach of GPCR-targeting cancer immunotherapies.With over two …See details»
Company - Domain Therapeutics Group
A unique GPCR company dedicated to Immuno-Oncology Our mission: delivering game-changing immunotherapies We are committed to improve patients’ life and to support physicians by delivering innovative immunotherapies to fight …See details»
Welcome to DTNA - Domain Therapeutics North America
Mar 4, 2024 Welcome to Domain Therapeutics North America ! Domain Therapeutics NA’s activities focus on leveraging Domain’s bioSensAllâ„¢ technology through:Research collaborations on the discovery of therapeutics …See details»
Who we are - Domain Therapeutics North America
Domain Therapeutics North America : Who we are. Domain Therapeutics North America (DTNA) a subsidiary of Domain Therapeutics was established in Montreal (Quebec, Canada) in 2014 and it is dedicated to the application and …See details»
Domain Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +33 3 90 40 61 50 Domain Therapeutics is a biopharmaceutical company located in Strasbourg, France, dedicated to the …See details»
About us - Domain Therapeutics North America
Domain Therapeutics NA Inc. adMare Institute - 7171 Frédérick Banting H4S 1Z9 Montreal - Canada https://www.domaintherapeutics.caSee details»
Domain Therapeutics - LinkedIn
Domain Therapeutics | 8,748 followers on LinkedIn. #biopharma #biotech #drugdiscovery #GPCR #Immunooncology #immunosuppression | Domain Therapeutics, a clinical-stage global biopharmaceutical ...See details»
Domain Therapeutics - PitchBook
Www.domaintherapeutics.com. Formerly Known As. Faust Pharmaceuticals. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. Parc d'Innovation; 220 Boulevard Gonthier …See details»
Domain Therapeutics Strengthens Leadership Team to …
Jan 8, 2024 ICR Consilium Amber Fennell, Namrata Taak Email: [email protected] Tel: +44 (0)20 3709 5813 Contacts. For more information, please contact:See details»
Our innovative approach - Domain Therapeutics Group
Unlocking new possibilities in immuno-oncology Our GPCR science is driven by patient needs Guided by our unwavering commitment to advancing therapeutic progress in cancer treatment, …See details»
Domain Therapeutics strengthens leadership team to spearhead …
Jan 8, 2024 Michael Gottlieb appointed as Chairman of the Board of Directors Anthony Johnson appointed as President and Chief Executive Officer Strasbourg, France – Montreal, Canada – …See details»
Contact us - Domain Therapeutics North America
Domain Therapeutics France [email protected]. Montreal. Domain Therapeutics NA Inc. adMare Institute - 7171 Frédérick Banting H4S 1Z9 Montreal - Canada . See on …See details»
Working with us - Domain Therapeutics North America
Domain Therapeutics SA Bioparc 1 - 850 Boulevard Sébastien Brant 67400 Strasbourg - Illkirch - France https://www.domaintherapeutics.comSee details»
Our Programs - Domain Therapeutics Group
Immuno-oncology programs. GPCRs constitute strategic targets mediating immunosuppression.The company exploits its expertise in the field to move forward small …See details»
Domain Therapeutics Raises $42m Series A Financing
May 10, 2022 Contact Domain Therapeutics: [email protected] Contact Media: NewCap Annie-Florence Loyer – [email protected] - +33 (6) 88 20 35 59 Juliette Milleret – …See details»
Domain Therapeutics - Craft
Domain Therapeutics has 5 employees across 2 locations and $41.48 m in total funding,. See insights on Domain Therapeutics including office locations, competitors, revenue, financials, …See details»
Our Collaborations - Domain Therapeutics North America
Domain Therapeutics NA is a key partner in multiple drug discovery collaborations Pfizer. On May 2017, a first collaboration with Pfizer aimed at assessing the impact of naturally occurring …See details»
Domain Therapeutics raises $42m Series A financing
May 10, 2022 www.domaintherapeutics.comAbout Panacea Venture Panacea Venture is a healthcare focused venture capital firm, with offices in Shanghai, Hong Kong, and Silicon …See details»
Domain Therapeutics enters into a new collaboration agreement …
Www.domaintherapeutics.com _____ Media and analysts contacts Andrew Lloyd & Associates Jo Reeder | Juliette Schmitt-dos Santos [email protected] - [email protected] Tel: +44 1273 675 10 …See details»